Physician profile
Jay Doshi
NPI 1255596649
$78,908.95
in general payments reported to CMS, 2019-2025
45 companies · $2,877 in 2025
The $2,877 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $19K · 2021: $13K · 2022: $3,818 · 2023: $2,117 · 2024: $3,209 · 2025: $2,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,672 · Travel and Lodging: $352 · Education: $117 · Entertainment: $45.58 · Consulting Fee: $15.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,672.30 |
| Travel and Lodging | $352.46 |
| Education | $117.27 |
| Entertainment | $45.58 |
| Consulting Fee | $15.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54,897.02 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $7,647.03 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Biotronik INC. | $6,745.17 | 2019-2021 | |
| Medtronic, INC. | $1,841.55 | 2021-2025 | Micra, Linq II, Reveal Linq |
| Boston Scientific Corporation | $1,676.35 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack, Momentum El Icd Vr |
| Stereotaxis INC | $653.81 | 2019-2024 | Genesis, Niobe |
| Angiodynamics, INC. | $648.01 | 2024-2025 | Alphavac |
| Pfizer INC. | $561.13 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $505.16 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $407.68 | 2022-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $339.06 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite, Perclose Prostyle |
| Cvrx, INC. | $283.42 | 2023-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $279.62 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $277.10 | 2023-2024 | Inpefa |
| Amgen INC. | $211.04 | 2019-2025 | Repatha, Repatha |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.